McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
ORMP holding history
Oramed Pharmaceuticals Inc. in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ORMP overviewAll 13F holders of ORMPFull Q1 2026 holdings
- Shares (Q1 2026)
- 1,000
- Value
- $3.40K
- % of portfolio
- <0.1%
- Quarters held
- 20
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 1,000 | $3.40K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,000 | $2.85K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,000 | $2.64K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,000 | $2.25K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,000 | $2.14K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,000 | $2.42K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,000 | $2.44K | <0.1% | −1,000−50.0% | Reduced | Holders |
| Q2 2024 | 2,000 | $5.14K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,000 | $5.84K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,000 | $4.62K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2,000 | $5.22K | <0.1% | −500−20.0% | Reduced | Holders |
| Q2 2023 | 2,500 | $8.95K | <0.1% | −500−16.7% | Reduced | Holders |
| Q1 2023 | 3,000 | $6.54K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 3,000 | $36.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 3,000 | $19.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 3,000 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 3,000 | $26.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 3,000 | $43.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 3,000 | $66.0K | <0.1% | −1,000−25.0% | Reduced | Holders |
| Q2 2021 | 4,000 | $54.0K | <0.1% | +4,000 | New | Holders |